diabetes mellitus is caused by a deficiency in the secretion or action of insulin. Nearly six percent of the United States population shows some degree of abnormality in glucose metabolism indicative of diabetes or a tendency toward the condition. Diabetes mellitus is a group of diseases in which the regulatory activity of insulin is defective. There are two major clinical classes of the disease. There’s type I, which is insulin-dependent diabetes mellitus (IDDM), and type II, which is non-insulin dependent diabetes mellitus (NIDDM).
IDDM begins early in life and quickly becomes severe.
NIDDM is slow to develop, milder, and often goes unrecognized. IDDM requires insulin therapy and careful, lifelong control of the balance between glucose intake and insulin dose. Characteristic symptoms of diabetes are excessive thirst (polydipsia) and frequent urination (polyuria), leading to intake of large volumes of water. Also, excessive hunger and food consumption (polyphagia).
These changes are due to excretion of large amounts of glucose in the urine. The term diabetes mellitus means “excessive excretion of sweet urine.” Suspected genes that cause IDDM are localized on many chromosomes, showing that type I diabetes is a multi gene autoimmune response.
Some investigators believe the immune system is confused. They think that the pancreatic beta cells could be recognized as an alien entity because of previous exposure to a foreign substance that had similar proteins to the beta cells. It’s believed that T cells target and enzyme glutamate decarboxylase (GAD) present in the beta cells. GAD coverts the amino acid glutamate into – aminobutyric acid (GABA), a messenger between neurons. GAD is located in the brain hidden from the immune system. Investigators are hinting that the immune system may not recognize it as a self-protein.
The Essay on Blood Sugar Diabetes Insulin Diabetic
... forms of diabetes and then I will discuss diabetes in general. 1. Insulin dependent diabetes (IDDM) or type ... Diabetes Mellitus Diabetes is the seventh leading cause of death listed in the United States. Diabetes ... -producing cells, the glucagon-synthesizing alpha cells and the more numerous insulin-producing beta cells. Insulin and ... Since the muscles work as a system, neuropathy can lead to other foot ...
GAD resembles the (p 69) protein that beta cells show when they are infected by viruses GAD plays an important, but it isn’t the entire answer. A group of mice disposed to develop diabetes were injected with GAD before the autoimmune response on the pancreas began and all the mice injected with GAD escaped development of diabetes. The affects of IDDM make the patients diseases more burdensome to control. They usually have vascular and neural problems. Vascular problems that affect IDDM patients are strokes, renal shutdown, gangrene, heart attacks, and blindness that could happen because of the high fat content in the blood and high blood cholesterol levels.
Neurological problems that arise from IDDM are loss of sensation, impotence and damaged bladder functions. In women, their breasts are lumpy and experience early menopause. NIDDM occurs mostly after the age of forty. It’s a heterogeneous, progressive disorder characterized by pathogenic defects in insulin secretion and action. Around a quarter to one-third of Americans possess a gene that sways them too the disease.
For example, if one identical twin has NIDDM, the chance of the other twin having the disease would be a one hundred percent. In NIDDM, the patient’s insulin receptors don’t work anymore, but they are still able to produce insulin. Investigators believe a membrane protein is responsible. They think it’s PC-1 because in NIDDM patients, it’s levels are higher compared to an average person.
Now we may be wondering why NIDDM patients need to diet and exercise, well nearly ninety percent of them are obese. This happens because the adipose cells over produce a hormone like chemical tumor necrosis factor-alpha. What this does is suppress the synthesis of a protein glut 4, which enables glucose to go through membranes. If glut 4 is not present, the cells can’t take up the glucose. In today’s market, there are a lot of prescriptions that are available to counter act the deficiency’s of IDDM and NIDDM patients.
The Essay on Diabetes 3 Insulin Blood Levels
Diabetes Mellitus is a disorder in which blood levels of glucose are abnormally high because the body doesn't release or use insulin adequately. Diabetes Mellitus affects many organs of the body. It affects the blood vessels because Atherosclerotic plaque builds up and blocks large or medium-sized arteries in the heart, brain, and legs. The walls of small blood vessels are damaged so that the ...
Such drugs are Actos, Star lix, Glucophage, and Avandia, which increase insulin reception for NIDDM, and Glipizide, Glyburide, Tolinase, and Tolbutamide, which increase insulin production for IDDM patients. For people who have IDDM, they have to inject themselves with insulin four times a day to reduce vascular and renal complications. NIDDM patients will also eventually have to inject themselves. A person can keep track of their glucose levels by using a glucose monitoring machine, which diabetics are not to fond of doing. Poking themselves with a lancet four times a day on their fingers is not fun. Eventually the patients’ fingers become raw after using lancets to draw blood to put on the strip for measurement of glucose levels.
They do have new machines that can measure glucose levels from blood by using the lancet on the forearm or wherever else the patient feels comfortable withdrawing a drop of blood from. An example of that would be the One Touch Ultra Glucose Monitoring System by Lifes can. These glucose-monitoring machines are very popular because the patient doesn’t have to poke only the fingers. I read in a journal that in the future we may be able to transplant islets for patients who have IDDM. islet cell transplantation can potentially normalize blood glucose levels and stop the progression of clinical complications, and if the transplant is done early in the course of the disease complications may be prevented. Progress has been made in recent years with Type 1 diabetes in the absence of hormones such as insulin that decrease blood glucose levels.
The Term Paper on Diabetes Mellitus Blood Glucose
... progression of long-term complications, These goals are likely to be met when the patient is able to maintain blood glucose levels as near to ... to an autoimmune process in susceptible individuals. Autoantibodies to the islet cells cause a reduction of 80% to 90% of ... I diabetes is associated with a long preclinical period. The islet cell auto antibodies responsible for B cell destruction are present ...
Only a few patients, however, have achieved insulin independence. Issues relating to islet cell engraftment within the liver, prevention of rejection and recurrent autoimmunity, and identification of alternative immunosuppressive drugs that do not adversely affect islet cell function remain to be solved. Identification of immuno intervention protocols that allow for engraftment in the absence of deleterious effects on the islets and prevent rejection and recurrent autoimmunity would make this procedure suitable for all patients, including children who have not yet developed long-term complications of the disease. Fortunately, both IDDM and NIDDM are treatable. Without the treatments, there would have been a lot of people and children dieing without experiencing life completely. The unfortunate thing is that the treatments are expensive without insurance.
Buying the medications and test strips every month can put a huge dent in a diabetic’s pocket. 1. Boca, Terry. Pharmacist, Walgreens Pharmacy. Telephone Interview. 4 th December 2001.
2. Kenyon, N. Ranuncoli, A. Mase tti, M. Chatzipetrou, M. Ricord i, C.
“Islet Transplantation: Present and Future Perspectives.” Diabetes and Metabolism Reviews Volume 14 (1998), pages 303-313. 3. Cox, M. Nelson, D. “Lehninger Principles of Biochemistry” 3 rd Edition (2000), NY, page 883. 4.
Stand, Eberhard. “Redefining treatment choice in type II diabetes, Highlights of the Experts’ Forum Meeting, Monte Carlo, 4-7 May 2000.” Journal of Diabetes and Its Complications Volume 15 (2001), pages 162-166.
